Sigyn Therapeutics, Inc. (SIGY)
OTCMKTS
· Delayed Price · Currency is USD
1.820
-0.180 (-9.00%)
At close: Dec 5, 2025
Sigyn Therapeutics Market Cap
Sigyn Therapeutics has a market cap or net worth of $2.92 million as of December 5, 2025. Its market cap has decreased by -87.35% in one year.
Market Cap
2.92M
Enterprise Value
5.65M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.82
Market Cap Chart
Since October 20, 2020, Sigyn Therapeutics's market cap has decreased from 66.98M to 2.92M, a decrease of -95.64%. That is a compound annual growth rate of -45.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 2.92M | -42.22% |
| Dec 17, 2024 | 5.06M | -16.78% |
| Dec 27, 2023 | 6.08M | -4.15% |
| Dec 29, 2022 | 6.34M | -66.00% |
| Dec 30, 2021 | 18.65M | -57.38% |
| Dec 31, 2020 | 43.76M | -34.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Elite Pharmaceuticals | 558.58M |
| Glass House Brands | 531.36M |
| CytoDyn | 403.93M |
| American Oncology Network | 367.13M |
| Northwest Biotherapeutics | 364.92M |
| Silence Therapeutics | 336.78M |
| Nika Pharmaceuticals | 259.91M |